Plasmid clone of human L-Myc cDNA.
Alternative name | SET-0249_2 |
---|---|
Clone info. | Plasmid clone of human L-Myc cDNA. |
Comment | PCR cloning, forward primer: gactacgactcgtaccagcact; reverse primer: ttagtagccagtgaggtatgcaa. Nucleotide substitution C1670A (G363G) to NM_001033081. |
Vector backbone | pGEM-3Zf(+) (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) transcript variant 1 cDNA |
Depositor|Developer | Nakamura, Yukio | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB06674 | pGEM3Zf_hsL-Myctv1 | DNA solution |
Materials & Methods section:
The pGEM3Zf_hsL-Myctv1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06674). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB13527_A5Ipp1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB13527_A5Ipa.seq |
---|
>06674_13527_A5Ip_M13(-40)_H02_23.ab1 1 AGGCAATTAA TTGTATACGA CTCACTATAG GGCGAATTCG AGCTCGGTAC CCGGGGATCC 61 TCTAGAGTCG ACTACGACTC GTACCAGCAC TATTTCTACG ACTATGACTG CGGGGAGGAT 121 TTCTACCGCT CCACGGCGCC CAGCGAGGAC ATCTGGAAGA AATTCGAGCT GGTGCCATCG 181 CCCCCCACGT CGCCGCCCTG GGGCTTGGGT CCCGGCGCAG GGGACCCGGC CCCCGGGATT 241 GGTCCCCCGG AGCCGTGGCC CGGAGGGTGC ACCGGAGACG AAGCGGAATC CCGGGGCCAC 301 TCGAAAGGCT GGGGCAGGAA CTACGCCTCC ATCATACGCC GTGACTGCAT GTGGAGCGGC 361 TTCTCGGCCC GGGAACGGCT GGAGAGAGCT GTGAGCGACC GGCTCGCTCC TGGCGCGCCC 421 CGGGGGAACC CGCCCAAGGC GTCCGCCGCC CCGGACTGCA CTCCCAGCCT CGAAGCCGGC 481 AACCCGGCGC CCGCCGCCCC CTGTCCGCTG GGCGAACCCA AGACCCAGGC CTGCTCCGGG 541 TCCGAGAGCC CAAGCGACTC GGAGAATGAA GAAATTGATG TTGTGACAGT AGAGAAGAGG 601 CAGTCTCTGG GTATTCGGAA GCCGGTCACC ATCACGGTGC GAGCAGACCC CCTGGATCCC 661 TGCATGAAGC ATTTCCACAT CTCCATCCAT CAGCAACAGC ACAACTATGC TGCCCGTTTT 721 CCTCCAGAAA GCTGCTCCCA AGAAGAGGCT TCAGAGAGGG GTCCCCAAGA AGAGGTTCTG 781 GAGAGAGATG CTGCAGGGGA AAAGGAAGAT GAGGAGGATG AAGAGATTGT GAGTCCCCCA 841 CCTGTAGAAA GTGAGGCTGC CCAGTCCTGC CACCCCAAAC CTGTCAGTTC TGATACTGAG 901 GATGTGACCA AGAGGAAGAA TCACAACTTC CTGGAGCGCA AGAGGCGGAA TGACCTGCGT 961 TCGCGATTCT TGGCGCTGAG GGACCAGGTG CCCACCCTGG CCCAGCTGCT CCAAGGCCCC 1021 AAGTAGTGAT CCCTAAGCAA AGGCCCTTGG AATACTTTGC AAGCCCTGAT GGGGGGCTGA 1081 GAGAGGATGG CCTACAGAGA AAAGACAGCT TCGAATGCTG GCAGGCCAGC CAGGTTGGCC 1141 AGAAAAAGAA ATTGCCAATT ACTCTCCAAC CCTGTGTC // |
Primer: Reverse2 Sequence file: RDB13527_A5Ipb.seq |
>06674_13527_A5Ip_Reverse2_A03_03.ab1 1 AATACAGATT ACGCCAGCTA TTTAGGTGAC ACTATAGAAT ACTCAAGCTT GCATGCCTGC 61 AGGTCTTAGT AGCCAGTGAG GTATGCAATT CTTTTCTGCA ACTGCTGCTG CCGGCATCGG 121 AGCTGTCTTT TCTCTGTAGC CATCCTCTTC TCAGCCCCCA CCAGGGCTTG CAAGTATTCC 181 AAGGCCTTGC TTAGGATCAC TACTTTGGGG GCCTTGGAGC AGCTGGCCAG GGTGGGCACC 241 TGGTCCCTCA GCGCCAAGAA TCGCGAACGC AGGTCATTCC GCCTCTTGCG CTCCAGGAAG 301 TTGTGATTCT TCCTCTTGGT CACATCCTCA GTATCAGAAC TGACAGGTTT GGGGTGGCAG 361 GACTGGGCAG CCTCACTTTC TACAGGTGGG GGACTCACAA TCTCTTCATC CTCCTCATCT 421 TCCTTTTCCC CTGCAGCATC TCTCTCCAGA ACCTCTTCTT GGGGACCCCT CTCTGAAGCC 481 TCTTCTTGGG AGCAGCTTTC TGGAGGAAAA CGGGCAGCAT AGTTGTGCTG TTGCTGATGG 541 ATGGAGATGT GGAAATGCTT CATGCAGGGA TCCAGGGGGT CTGCTCGCAC CGTGATGGTG 601 ACCGGCTTCC GAATACCCAG AGACTGCCTC TTCTCTACTG TCACAACATC AATTTCTTCA 661 TTCTCCGAGT CGCTTGGGCT CTCGGACCCG GAGCAGGCCT GGGTCTTGGG TTCGCCCAGC 721 GGACAGGGGG CGGCGGGCGC CGGGTTGCCG GCTTCGAGGC TGGGAGTGCA GTCCGGGGCG 781 GCGGACGCCT TGGGCGGGTT CCCCCGGGGC GCGCCAGGAG CGAGCCGGTC GCTCACAGCT 841 CTCTCCAGCC GTTCCCGGGC CGAGAAGCCG CTCCACATGC AGTCACGGCG TATGATGGAG 901 GCGTAGTTCC TGCCCCAGCC TTTCGAGTGG CCCCGGGATT CCGCTTCGTC TCCGGTGCAC 961 CCTCCGGGCC ACGGCTCCGG GGGACCAATC CCGGGGGCCG GGTCCCCTGC GCCGGGACCC 1021 AGCCCCAGGC GCGACGTGGG GGGGCGATGC ACCAGCTCGA TTCTTCCAGA TGTCTCGCTG 1081 GGCGCCGTTG AAGCGTTAGA ATCTCCCGCA GTCATAGTCG TAGAAATAGT GCTTGCTTAC 1141 GAGTCGGTTA GTCCGAACT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content